Ingesting Risk - The FDA and New Food Ingredients

被引：0

作者：

Cohen, Pieter A. ^{[1
,2
]}

Leib, Emily M. Broad ^{[3
]}

机构：

[1] Cambridge Hlth Alliance, Cambridge, MA 02139 USA

[2] Harvard Med Sch, Boston, MA 02115 USA

[3] Harvard Law Sch, Food Law & Policy Clin, Cambridge, MA USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 10期

关键词：

Drug and Device Safety; Health Policy; Medicine and the Law; Public Health;

D O I：

10.1056/NEJMp2403165

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Ingesting Risk Food additives that are "generally recognized as safe" - a determination that can be made by manufacturers - aren't required to be approved by the FDA. This system could pose a threat to public health.

引用

页码：875 / 877

页数：3

共 50 条

[1] FDA's New Risk Communication Advisory Committee
Reactions Weekly, 2007, 1155 (1) : 2 - 2
[2] The essential ingredients of food regulatory governance
Arup, Christopher
Dixon, Jane
Paul-Taylor, Jo
GRIFFITH LAW REVIEW, 2020, 29 (02) : 273 - 301
[3] US FDA wants balance in risk information
Reactions Weekly, 2009, 1255 (1) : 2 - 2
[4] A Comprehensive Strategy to Overhaul FDA Authority for Misleading Food Labels
Pomeranz, Jennifer L.
AMERICAN JOURNAL OF LAW & MEDICINE, 2013, 39 (04) : 617 - 647
[5] FDA issues safety advice on cefepime seizure risk
Reactions Weekly, 2012, 1409 (1) : 4 - 4
[6] Infants at risk with OTC use of benzocaine, says FDA
Reactions Weekly, 2012, 1407 (1) : 3 - 3
[7] FDA takes actions to reduce risk of dextropropoxyphene OD
Reactions Weekly, 2009, 1260 (1) : 2 - 2
[8] Antipsychotics a risk to neonates during pregnancy warns FDA
Reactions Weekly, 2011, 1341 (1) : 2 - 2
[9] FDA targets misconduct in new product development
Reactions Weekly, 2009, 1265 (1) : 2 - 2
[10] New FDA recommendations for lenalidomide and skin reactions
Reactions Weekly, 2009, 1259 (1) : 3 - 3

← 1 2 3 4 5 →